Ryan T Mott Selected Research

PT2385

1/2020	Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor.
1/2018	Hypoxia-inducible factor 2α: a novel target in gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryan T Mott Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 03/2004
2	Hypoxia (Hypoxemia) 01/2020 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 12/2017
2	Meningioma (Meningiomas) 12/2017 - 05/2012
1	Thrombocytopenia (Thrombopenia) 09/2021
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Glioma (Gliomas) 01/2018
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 05/2015
1	Astrocytoma (Pilocytic Astrocytoma) 05/2015
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Medulloblastoma 07/2011
1	Primitive Neuroectodermal Tumors (PNET) 05/2010
1	Teratoma (Teratoid Tumor) 05/2010
1	Hippocampal Sclerosis 10/2009
1	Temporal Lobe Epilepsy 10/2009
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2006
1	Amyloid Plaque 09/2006
1	Motor Neuron Disease (Primary Lateral Sclerosis) 05/2005
1	Corticobasal Degeneration 05/2005
1	Pick Disease of the Brain (Pick's Disease) 05/2005
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 05/2005
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 05/2005
1	Dementia (Dementias) 05/2005
1	Adenocarcinoma 01/2005
1	Hyperplasia 09/2002
1	Melanoma (Melanoma, Malignant) 09/2002

Drug/Important Bio-Agent (IBA)

3	Biological ProductsIBA 10/2013 - 03/2004
2	PT2385IBA 01/2020 - 01/2018
1	endothelial PAS domain-containing protein 1IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	MethyltransferasesIBA 10/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Cyclin D1IBA 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 05/2010
1	ChromatinIBA 05/2010
1	Pharmaceutical PreparationsIBA 10/2009
1	Amyloid beta-PeptidesIBA 09/2006
1	Amyloid (Amyloid Fibrils)IBA 09/2006
1	Proteins (Proteins, Gene)FDA Link 09/2006
1	Messenger RNA (mRNA)IBA 09/2006
1	CytokinesIBA 09/2006
1	tau Proteins (tau Protein)IBA 05/2005
1	UbiquitinIBA 05/2005
1	Apolipoprotein E4IBA 05/2005
1	Colloids (Colloid)IBA 01/2005
1	ErbB Receptors (EGF Receptor)IBA 09/2002

Therapy/Procedure

2	Salvage Therapy 05/2015 - 05/2012
1	Platelet Transfusion (Blood Platelet Transfusions) 09/2021
1	Chemoradiotherapy 01/2020
1	Immunotherapy 12/2017
1	Radiotherapy 12/2017
1	Drug Therapy (Chemotherapy) 05/2015
1	Aftercare (After-Treatment) 05/2012
1	Re-Irradiation 07/2011